Searchable abstracts of presentations at key conferences in endocrinology

ea0024bc1.3 | (1) | BSPED2010

Experience of management of children and adolescents with thyrotoxicosis in the West of Scotland 1987–2009

Altowati Mabrouka , Paterson Wendy , Ahmed Faisal , Williamson Scott , Hunt Gerald , Hunter Ian , Donaldson Malcolm

Background: Hyperthyroidism is a significant medical condition in paediatric patients with serious health consequences. Optimal treatment remains debatable.Objective: To review 23 years’ experience of paediatric hyperthyroidism in the West of Scotland.Methods: Case notes of patients treated for thyrotoxicosis in Glasgow, Paisley, Ayrshire and Lanarkshire from 1987 until 2009 inclusive were retrospectively reviewed. Patients wi...

ea0021p115 | Clinical practice/governance and case reports | SFEBES2009

Endocrinopathy and low bone mineral density in thalassaemia

Waterhouse Mona , Gorrigan Rebecca , Thomas Aldine , Brooke Antonia , Telfer Paul , Kaya Banu , Akker Scott

Thalassaemia patients are transfusion dependent and at risk of iron overload with end organ damage. Iron deposition is reduced by chelation treatment. We present the data on endocrinopathy and bone density in the adult patients under our care with thalassaemia. In addition, we will discuss therapeutic approaches to these problems including the use of newer chelation agents and possible reversal of endocrine end organ damage. We will also review the correlation in our patients ...

ea0021p216 | Endocrine tumours and neoplasia | SFEBES2009

Expression and regulation of oestrogen sulfotransferase (EST) in human ovarian surface epithelium (OSE) and epithelial ovarian cancer (EOC)

Ren Xia , Harlow Chris , Fegan Scott , Mason Ian , Critchley Hilary , Hillier Stephen

Ovarian cancer is the most fatal of all gynaecological malignancies. EOC accounts for >90% of malignant ovarian tumours and is thought to originate mostly from OSE cells. Epidemiological data suggest EOC is oestrogen responsive and we previously showed active oestrogen could be produced locally by EOC cells, but not by normal OSE cells, through the combined activities of steroid sulfatase (STS) and 17βhydroxysteroid dehydrogenase. We now investigate if EST, which conv...

ea0021p339 | Steroids | SFEBES2009

Analysis of cortisol by stable isotope dilution liquid chromatography–tandem mass spectrometry (LC–MS/MS): pitfalls of rapid LC–MS/MS analysis of clinical samples

Homer Natalie , Denham Scott , Stimson Roland , Watson David , Walker Brian , Andrew Ruth

The glucocorticoid hormone, cortisol, regulates fuel metabolism, inflammation and stress–responses. Its circulating concentrations are tightly controlled by the hypothalamic–pituitary–adrenal axis. However, 11β-hydroxysteroid dehydrogenase 1 (11βHSD1) generates additional cortisol in tissues, by reduction of inert cortisone. Using a tracer (9,11,12,12[2H]4-cortisol; d4-cortisol), the velocity of 11βHSD1 can be determined as t...

ea0021p345 | Steroids | SFEBES2009

Dexamethasone testing and visceral:subcutaneous fat ratios in patients with adrenal incidentalomas

Debono Miguel , Hughes Tim , Durrington Charlotte , Williams Scott , Newell-Price John

Background: The Endocrine Society clinical practice guidelines suggest use of the 1 mg overnight dexamethasone suppression test (ONDST) to screen for cortisol excess in patients with adrenal incidentalomas, followed by the 48-h, 2 mg/day, low-dose dexamethasone-suppression test (LDDST), to confirm a positive result. Visceral fat accumulates in cortisol-excess and accounts for increased cardiovascular risk. In this study, we investigate whether the LDDST offers additional infor...

ea0021p362 | Steroids | SFEBES2009

MicroRNA expression profiling of non-tumorous adrenal tissue and modulation of 11β-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes by miR-24

Wood Stacy , MacKenzie Scott , Stewart Paul , Fraser Robert , Connell John , Davies Eleanor

The CYP11B1 and CYP11B2 genes encode 11β-hydroxylase and aldosterone synthase, which catalyse the production of cortisol and aldosterone, respectively, and have been implicated in the development of hypertension. For this study, we wished to investigate the role of microRNAs (miRNAs), a novel class of post-transcriptional gene regulators. To that end, we generated a profile of human adrenal miRNAs to study, and then investigated the action of one adrenal miR...

ea0019p282 | Reproduction | SFEBES2009

Clot structure and fibrinolysis in individuals with polycystic ovary syndrome: the effects of metformin, orlistat and pioglitazone treatment

Ajjan R , Chow L , Scott E , Carter A , Phoenix F , Grant P , Atkin S

Polycystic ovary syndrome (PCOS), which affects 7% of the female population, is associated with established cardiovascular risk factors including obesity, dyslipidaemia and insulin resistance. Thrombus formation represents the final step in the atherothrombotic process and clot structure has been shown to predict the predisposition to cardiovascular events. The aim of the present work was to assess the effects of commonly used therapeutic agents on clot structure and fibrinoly...

ea0015p74 | Clinical practice/governance and case reports | SFEBES2008

An adrenaline-secreting phaeochromocytoma in pregnancy

Thomas Julia , Vearncombe Laura , Perry Les , Sanghi Anita , Carpenter Robert , Akker Scott

A 37-year-old woman, 30 weeks pregnant, presented with palpitations and abdominal cramps. Ultrasound demonstrated a supra-renal abnormality and MRI showed a 10 cm heterogeneous left adrenal mass. For five years she had experienced episodes of palpitations, shaking, sweating and chest tightness. She was investigated by a neurologist and diagnosed with temporal lobe epilepsy. During pregnancy the frequency of episodes increased. Lamotrigine was started, but at each dose increase...

ea0015p91 | Clinical practice/governance and case reports | SFEBES2008

Growth hormone replacement in patients with treated germ cell tumours: safety issues

Chung Teng-Teng LL , Kelly Phillip , Metcalfe Karl , Akker Scott , Drake William , Monson John

The potential for primary tumour relapse is an important consideration during GH replacement therapy (GHR). We report 3 cases of relapse of intra cranial germ cell tumour (GCT) during GHR.Patient 1: An 11 year-old female presenting with visual loss and short stature due to a suprasellar malignant teratoma. She was successfully treated with bleomycin, etoposide and cisplatinum (BEP) and intrathecal chemotherapy. She suffered a first relapse two years late...

ea0015p128 | Diabetes, metabolism and cardiovascular | SFEBES2008

Is retinol binding protein a marker of insulin resistance in first-degree relatives of men with intermittent claudication (IC)?

Singh Narinder , Carter Angela , Boothby May , Parry Duncan , Julian Scott D , Summers Lucinda

Objective: Insulin resistance (IR) has been reported in first-degree male relatives of patients with IC (FDMR). Retinol binding protein-4 (RBP4) has been shown to be increased in IR. We hypothesized that RBP4 would be: 1) increased in FDMR compared with controls and 2) correlated with features of IR.Methods: The study was approved by Leeds (West) Research Ethics Committee. We measured RBP4 in 162 healthy FDMR previously found to be more insulin resistant...